Staar Surgical Co (Staar Surgical Co) Days Sales Outstanding

: 123.87 (As of Dec. 2023)

View and export this data going back to 1983. Start your Free Trial

Staar Surgical Co's average Accounts Receivable for the three months ended in Dec. 2023 was $103.5 Mil. Staar Surgical Co's Revenue for the three months ended in Dec. 2023 was $76.3 Mil. Hence, Staar Surgical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 123.87.

The historical rank and industry rank for Staar Surgical Co's Days Sales Outstanding or its related term are showing as below:

STAA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.55 Med: 68.45 Max: 96.78
Current: 96.78

During the past 13 years, Staar Surgical Co's highest Days Sales Outstanding was 96.78. The lowest was 51.55. And the median was 68.45.

STAA's Days Sales Outstanding is ranked worse than
77.87% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 63.91 vs STAA: 96.78

Staar Surgical Co's Days Sales Outstanding increased from Dec. 2022 (83.97) to Dec. 2023 (123.87).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Staar Surgical Co Days Sales Outstanding Historical Data

The historical data trend for Staar Surgical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

69.19

73.94

62.37

68.01

88.95

Staar Surgical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																83.97	78.15	78.06	117.49	123.87

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staar Surgical Co Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Days Sales Outstanding falls into.

Staar Surgical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Staar Surgical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (62.447	+	94.704)	/	2 )	/	322.415	*	365
=	78.5755					/	322.415	*	365
=	88.95

Staar Surgical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (112.367	+	94.704)	/	2 )	/	76.273	*	365 / 4
=	103.5355					/	76.273	*	365 / 4
=	123.87

Staar Surgical Co (NAS:STAA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Staar Surgical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Staar Surgical Co (Staar Surgical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SR3:Germany SR3:Germany

Address

25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630

Website

https://www.staar.com

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Executives

Broadwood Partners Lp	10 percent owner	BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Elizabeth Yeu Lin	director	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Aimee S Weisner	director	ONE EDWARDS WAY, IRVINE CA 92614
Warren Foust	officer: Chief Operating Officer	17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna	officer: Chief Clinical, Regulatory,	C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday	officer: V.P., Research & Development	1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme	officer: Senior VP, Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese	officer: VP, Global Marketing	1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason	director	2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten	officer: VP, General Counsel	1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams	officer: Chief Financial Officer	C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer	officer: VP, International Marketing	1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman	director
Graydon C. Hansen	officer: Sr. VP, Global Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida	officer: VP, Global Clinical, Medical	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630